Dermata Therapeutics, Inc.

DRMA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001853816

SEC filings (opens in a new tab)

No open-market purchases or sales by Dermata Therapeutics, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $158.0K in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Dermata Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of DRMA: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Q2 2025	Change
Holders	8	10	+2
Shares	518.5K	508.2K	−10.4K (−2.0%)
Value	$561.2K	$297.5K	−$263.7K (−47.0%)

New holders (3)

Institutions that held Dermata Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to DRMA in Q2 2025
Institution	Shares	Value	% of portfolio
XTX Topco Ltd	34,492	$20.2K	0.00%
Two Sigma Securities, LLC	14,724	$8.61K	0.00%
Citigroup Inc	60	$35	0.00%

Sold out (1)

Institutions that held Dermata Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of DRMA in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Wells Fargo & Company	2,000	$2.16K